![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](ci6442contents.gif)
Acta Cryst. (2004). E60, o1786-o1787 [ doi:10.1107/S1600536804022275 ]
Abstract: The title compound, C4H3FN2O2·C2H6OS, crystallizes in the monoclinic space group P21/c, with one molecule of 5-fluorouracil and one molecule of dimethyl sulfoxide (DMSO) in the asymmetric unit. The crystal structure contains hydrogen-bonded ribbons of alternating 5-fluorouracil and DMSO molecules which stack, forming non-interacting layers parallel to the (100) planes.
Online 18 September 2004
Copyright © International Union of Crystallography
IUCr Webmaster